NCT02458690 eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients Status COMPLETED Phase PHASE2
NCT02454426 Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease Status WITHDRAWN Phase EARLY_PHASE1
NCT02443584 Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis Status COMPLETED Phase NA
NCT02440815 Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression Status COMPLETED Phase NA
NCT02436239 A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02431806 Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02427789 Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major Depression Status COMPLETED Phase NA
NCT02422303 Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms Status TERMINATED Phase NA
NCT02421965 Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness Status COMPLETED Phase NA
NCT02418195 miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome Status COMPLETED Phase PHASE2
NCT02409823 Clinical Registry of Patients Under Treatment With Atypical Antipsychotics Status COMPLETED Phase N/A
NCT02407704 A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise Status COMPLETED Phase PHASE4
NCT02398877 HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms Status COMPLETED Phase NA
NCT02395978 A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2